P&G to acquire supplement company Thorne for US$3.8B to boost health portfolio

P&G has entered into a definitive agreement to acquire Thorne, which will join its Health Care portfolio. With the acquisition, P&G expects to better meet growing consumer demand for preventive and personalized health. 

Investment firm L Catterton has reported that it is selling Thorne for US$3.8 billion. P&G’s CEO, Shailesh Jejurikar, confirmed this purchase price in an interview with CNBC yesterday.

Thorne provides health and wellness solutions to consumers, athletes, and health care professionals. 

Paul Gama, CEO of P&G Health Care, says the acquisition is an important step for the business. “Consumer interest in self-care, prevention, wellness, and personalized health continues to grow, and Thorne strengthens our position in premium wellness with a trusted, science-backed brand that complements our existing portfolio.”

The transaction is expected to close in the fourth quarter of 2026, subject to customary closing conditions and regulatory approvals. 

Personalized health

Thorne says that the acquisition will help it further build its personalized health brand by helping consumers live healthier with efficacious solutions. 

“For more than 40 years, Thorne has earned the trust of health care practitioners, consumers, and partners by putting science, quality, and the people we serve at the center of every decision,” says Colin Watts, CEO of Thorne. 

“P&G is the right partner to help us expand our impact while staying true to the values and standards that have always defined Thorne.”

Thorne’s portfolio includes supplements and technology, such as its AI-powered wellness advisor Taia. 

Gama of P&G adds: “We see an opportunity to bring Thorne’s science-backed wellness solutions to more consumers while continuing to build on the quality, credibility, and innovation that have made the brand successful.”

Wellness mergers & acquisitions

P&G’s acquisition of Thorne is the latest in a range of business deals in the nutrition and health space. 

H&H Group’s CFO previously told Nutrition Insight that there is a strong appetite for acquisitions and investments into the health and wellness market, specifically in nutrition. 

“Established businesses are recognizing that acquiring health and wellness brands, with loyal consumer bases and proven efficacy, is the fast route to diversification and growth,” said Jason Wang.

Recent acquisitions include Lactalis’ purchase of the UK active nutrition brand Protein Works, while Unilever made a deal to acquire the US-based green supplement company Grüns. 

Additionally, functional ingredients supplier SuanNutra signed an agreement to buy a portfolio of specialty natural ingredients from IFF, and Ingredion purchased the Benicaros prebiotic from NutriLeads as a strategic addition to its Healthful Solutions portfolio.